Free Market Research Guides to Download
» Download Public Reports
1-30 of about 500 reports
... Contained in our forward-looking statements, whether as a result of new information, future events or otherwise. Complete genomics, inc. Condensed consold statements of comprehensive loss (in thousands ...
... Of financial results for the full year or any other interim period. The company operates as one segment, providing whole human genome sequencing and analysis. The condensed consold financial statements ...
... Of complete genomics, inc., A delaware corporation (the Company ), At a purchase price of $3.15 Per share, net to the seller in cash, without interest thereon, less any required withholding taxes, upon ...
... Of complete genomics, inc., A delaware corporation (the Company ), At a purchase price of $3.15 Per share, net to the seller in cash, without interest thereon, less any required withholding taxes, upon ...
... Breakthrough turnaround time, available via illumina's clia-certified laboratory Announced an alliance with partners healthcare to introduce next-generation sequencing (ngs) clinical interpretation ...
... On the opportunities and risks associated with: the company S business and financial condition; the rapidly changing technologies, demand and competition for whole human genome sequencing; and possible sources ...
... Of diseases. microrna S big role according to the filing, Micrornas are recently discovered, naturally occurring ribonucleic acid, or rna, molecules that play a critical role in regulating key biological ...
... Stage, already accomplished and consistent with the mandate, signature dna is on the microchips produced in the dla S generalized emulation of microcircuits program, known as gem. In the mandated ...
... microrna field, and that as a result, we have developed an early and strong intellectual property position related to the development and commercialization of microrna-based diagnostics. Using our ...
... Bgi-shenzhen completes acquisition of complete genomics combined company to focus on high volume, accurate human genomic sequencing and accelerating the spread of genomic medicine shenzhen, china ...
... Addressing the privacy of human genome sequence data. Some of the recommendations may impact non-profit organizations that fund genomic research, such as research foundations, institutes and patient advocacy ...
... In pharmaceutical research, as well as many other fields, including agriculture, pathology, biomarker discovery, biodefense and forensics. Laesi is intended to meet the broad need of the biologist for the direct ...
... Mg of m-mulv protein as described previously (7). The deproteinized rna was purified further by a second sodium dodecyl sulfate (sds)-sucrose gradient cen- trifugation, recovered by ethanol ...
... And execution expertise rosetta S microrna advantage: micrornas are acknowledged as outstanding biomarkers: master gene regulators, highly tissue specific, in most major diseases and extremely stable ...
... pharmacogenomics and pharmacogenetics are a growing phenomenon and as such over xxx publically funded research organisations worldwide are currently investigating personalized medicine as a plausible cand ...
... Unpublished data Waiting on patents) now hiring a senior scientist in computational biology to join the grassroots computational gene regulation engineering team gfp expression in root tip, driven ...
... Of the 63 respondents that have an ehr, 65% report ability to easily & efficiently capture genetics information and fh as fair or poor 12 results Incentives 0% 50% 100% easier access ...
... Systems approaches to crop improvement Modelling wp1 wp2 wp3 wp4 where knowledge grows rothamsted research key objectives Exploit variation and biotechnology to increase biomass (nue ...
... Useful database systems; private and public advances in new technologies as high throughput next generation sequencing availability of numerous helpful software tools fragmented, in some ...
... Recruitment biomarker discovery biomarker validation clinical validation Second most frequent cancer in the developed world Current tests low specificity and poor patient compliance Ogt ...
... Medicine (pm) based on personal genome to revolu- tionize the next generation healthcare. Diagnomics applies modern genomics technologies to the development of pro- ducts and services that translate ...
... Select superior animals as parents of future generations phenotyp e pedigree statistical methodology predicted genetic merit genetic evaluations - limitations Slow Progeny testing for production ...
... By organizing different workshops on cellular and molecular biology assays in order to explore the effect of physical and chemical agents on human dna by analysing chromosomal alterations. Why 1. Dna ...
... Are dna Recombinant dna sequencing dna Automation Scale-up shared features: rapidly accelerating power, drop in price. Ubiquity. Pervasiveness. Disruption. Unanticipated uses. Network ...
... Which to recoup testing costs. N need to capture the cumulative supply chain value derived from using genomics for multiple purposes (selection, parentage, genetic defects, marker-assisted management ...
» Purchase Premium Reports (From $ 125 - $ 2 795)
About 200 reports
The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by the worlds ...
» Read our Company Profiles
2 CompaniesReportlinker.com © Copyright 2013. All rights reserved.